BioCardia, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioCardia, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2019-09-30 was $1.21M.
- BioCardia, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $1.20M.
- BioCardia, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $12.16M, a 56.23% increase from fiscal 2015.
- BioCardia, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2015 was $7.78M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2019-12-31 | $1.20M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $1.21M 10-Q · filed 2020-11-10 | |
| 2016-12-31 | $12.16M 10-K · filed 2019-04-02 | |
| 2015-12-31 | $7.78M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |